U.S. Appeals Court Upholds Lipitor’s Basic Patent With Exclusivity Maintained In U.S. Until March, 2010 (Medical News Today)

U.S. Appeals Court Upholds Lipitor’s Basic Patent With Exclusivity Maintained In U.S. Until March, 2010 (Medical News Today)
Pfizer Inc said today that a panel of the Court of Appeals for the Federal Circuit has upheld the exclusivity of the main patent covering atorvastatin, the active ingredient in Lipitor, maintaining patent protection for Lipitor in the U.S. until March 2010. The Appeals Court also ruled that a second patent (U.S. [click link for full article]